Published June 30, 2025
| Version v1
Journal article
Open
A Rare Case of Liddle Syndrome Due To A Novel Mutation in A Normotensive Adult
Authors/Creators
- 1. International Journal of Medical Science and Advanced Clinical Research (IJMACR)
Description
Abstract
Liddle syndrome (pseudoaldosteronism) is a genetically heterogenous autosomal dominant disorder. The key clinical characteristics of this syndrome are early onset salt-sensitive hypertension with hypokalemia, metabolic alkalosis, inhibition of renin activity and aldosterone secretion. Liddle syndrome is caused by mutations (missense or frameshift) in the genes of epithelial sodium channel (ENaC) subunits namely SCNN1A, SCNN1B or SCNN1G genes.
A normotensive adult diabetic male with CKD presenting with hypokalemic paralysis, was found to have Liddle syndrome after ruling out commoner causes. The genetic analysis revealed a novel mutation in α subunit of ENaC. This is likely the second SCNN1A mutation identified after the description of one case of germ line mutation in the α subunit in a Caucasian family affected by Liddle syndrome by Salih M.
Files
UTPAL.pdf
Files
(920.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:919963bd9a105fe567a18ab9db575607
|
920.8 kB | Preview Download |
Additional details
Software
- Repository URL
- https://ijmacr.com/issue/archive_issue/61
References
- 1. Yang KQ, Xiao Y, Tian T, Gao LG, Zhou XL. Molecular genetics of Liddle's syndrome. Clinica Chimica Acta. 2014 Sep 25;436:202-6. 2. Garty H, Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiological reviews. 1997 Apr 1;77(2):359-96. 3. Büsst CJ. Blood pressure regulation via the epithelial sodium channel: from gene to kidney and beyond. Clinical and Experimental Pharmacology and Physiology. 2013 Aug;40(8):495-503. 4. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, Rossier BC. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature. 1994 Feb 3;367(6462):463-7. 5. Hanukoglu I, Hanukoglu A. Epithelial sodium channel (ENaC) family: Phylogeny, structure–function, tissue distribution, and associated inherited diseases. Gene. 2016 Apr 1;579(2):95-132. 6. Staruschenko A, Medina JL, Patel P, Shapiro MS, Booth RE, Stockand JD. Fluorescence resonance energy transfer analysis of subunit stoichiometry of the epithelial Na+ channel. Journal of Biological Chemistry. 2004 Jun 25;279(26):27729-34. 7. Jasti J, Furukawa H, Gonzales EB, Gouaux E. Structure of acid-sensing ion channel 1 at 1.9 Å resolution and low pH. Nature. 2007 Sep 20;449(7160):316-23. 8. Schild L, Lu Y, Gautschi I, Schneeberger E, Lifton RP, Rossier BC. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. The EMBO journal. 1996 May 15;15(10):2381-7. 9. Rotin D, Staub O. Role of the ubiquitin system in regulating ion transport. Pflügers Archiv-European Journal of Physiology. 2011 Jan;461:1-21. 10. Butterworth MB. Regulation of the epithelial sodium channel (ENaC) by membrane trafficking. Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease. 2010 Dec 1;1802(12):1166-77. 11. Wang LP, Yang KQ, Jiang XJ, Wu HY, Zhang HM, Zou YB, Song L, Bian J, Hui RT, Liu YX, Zhou XL. Prevalence of Liddle syndrome among young hypertension patients of undetermined cause in a Chinese population. The Journal of Clinical Hypertension. 2015 Nov;17(11):902-7. 12. Liu K, Qin F, Sun X, Zhang Y, Wang J, Wu Y, Ma W, Wang W, Wu X, Qin Y, Zhang H. Analysis of the genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients. Journal of hypertension. 2018 Mar 1;36(3):502-9. 13. Salih M, Gautschi I, Van Bemmelen MX, Di Benedetto M, Brooks AS, Lugtenberg D, Schild L, Hoorn EJ. A missense mutation in the extracellular domain of αENaC causes Liddle syndrome. Journal of the American Society of Nephrology. 2017 Nov 1;28(11):3291-9. 14. Pepersack T, Allegre S, Jeunemaître X, Leeman M, Praet JP. Liddle syndrome phenotype in an octogenarian. The Journal of Clinical Hypertension. 2014 Nov 27;17(1):59. 15. Gonzalez-Rodriguez E, Gaeggeler HP, Rossier BC. IGF-1 vs insulin: respective roles in modulating sodium transport via the PI-3 kinase/Sgk1 pathway in a cortical collecting duct cell line. Kidney international. 2007 Jan 2;71(2):116-25. 16. Ilatovskaya DV, Levchenko V, Brands MW, Pavlov TS, Staruschenko A. Cross-talk between insulin and IGF-1 receptors in the cortical collecting duct principal cells: implication for ENaC-mediated Na+ reabsorption. American Journal of Physiology-Renal Physiology. 2015 Apr 1;308(7):F713-9. 17. Mansley MK, Watt GB, Francis SL, Walker DJ, Land SC, Bailey MA, Wilson SM. Dexamethasone and insulin activate serum and glucocorticoid‐inducible kinase 1 (SGK1) via different molecular mechanisms in cortical collecting duct cells. Physiological reports. 2016 May;4(10):e12792. 18. Pavlov TS, Ilatovskaya DV, Levchenko V, Li L, Ecelbarger CM, & Staruschenko A (2013). Regulation of ENaC in mice lacking renal insulin receptors in the collecting duct. FASEB J, 27(7), 2723 2732. 10.1096/fj.12-223792 [PubMed: 23558339] 19. McCormick JA, Bhalla V, Pao AC, Pearce D. SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption. Physiology. 2005 Apr;20(2):134-9. 20. Song J, Knepper MA, Verbalis JG, Ecelbarger CA. Increased renal ENaC subunit and sodium transporter abundances in streptozotocin-induced type 1 diabetes. American Journal of Physiology-Renal Physiology. 2003 Dec;285(6):F1125-37. 21. Ray EC, Miller RG, Demko JE, Costacou T, Kinlough CL, Demko CL, Unruh ML, Orchard TJ, Kleyman TR. Urinary plasmin (ogen) as a prognostic factor for hypertension. Kidney international reports. 2018 Nov 1;3(6):1434-42. 22. Svenningsen P, Skøtt O, Jensen BL. Proteinuric diseases with sodium retention: is plasmin the link?. Clinical and Experimental Pharmacology and Physiology. 2012 Jan;39(1):117-24. 23. Buhl KB, Oxlund CS, Friis UG, Svenningsen P, Bistrup C, Jacobsen IA, Jensen BL. Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro. Journal of hypertension. 2014 Aug 1;32(8):1672-7. 24. Andersen H, Friis UG, Hansen PB, Svenningsen P, Henriksen JE, Jensen BL. Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells. Nephrology Dialysis Transplantation. 2015 May 1;30(5):781-9. 25. Unruh ML, Pankratz VS, Demko JE, Ray EC, Hughey RP, Kleyman TR. Trial of amiloride in type 2 diabetes with proteinuria. Kidney international reports. 2017 Sep 1;2(5):893-904. 26. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N (epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging. The Journal of clinical investigation. 1997 Feb 1;99(3):457-68. 27. Wang Q, Song B, Jiang S, Liang C, Chen X, Shi J, Li X, Sun Y, Wu M, Zhao D, Zhang ZR. Hydrogen Sulfide Prevents Advanced Glycation End‐Products Induced Activation of the Epithelial Sodium Channel. Oxidative Medicine and Cellular Longevity. 2015;2015(1):976848.